GMTX
Gemini Therapeutics, Inc.·Healthcare
1.35
0.000%(+0.00)
Close PriceLast Updated: — ET
52W L: $1.3552W H: $24.70
Gemini Therapeutics, Inc.·Healthcare
SAN FRANCISCO--(BUSINESS WIRE)-- #ASCO--Gemini Therapeutics Announces ASCO 2026 Analyses Supporting Aldoxorubicin's Tumor-Targeted Delivery and Cardiac-Safety Profile.
The FDA in the past year has denied or discouraged applications of at least eight new drugs, according to RTW Investments. The agency initially refused to review Moderna's flu shot before reversing course.
iBio (NASDAQ: IBIO - Get Free Report) and Gemini Therapeutics (NASDAQ: GMTX - Get Free Report) are both manufacturing companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Valuation and Earnings This table compares iBio and Gemini
